<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d322" origId="Clorazepate"><sentence id="DrugDDI.d322.s0" origId="s0" text="If TRANXENE is to be combined with other drugs acting on the central nervous system, careful consideration should be given to the pharmacology of the agents to be employed."><entity id="DrugDDI.d322.s0.e0" origId="s0.p0" charOffset="3-11" type="drug" text="TRANXENE"/><entity id="DrugDDI.d322.s0.e1" origId="s0.p5" charOffset="41-46" type="drug" text="drugs"/><pair id="DrugDDI.d322.s0.p0" e1="DrugDDI.d322.s0.e0" e2="DrugDDI.d322.s0.e1" interaction="false"/></sentence><sentence id="DrugDDI.d322.s1" origId="s1" text="Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition."><entity id="DrugDDI.d322.s1.e0" origId="s1.p18" charOffset="33-56" type="drug" text="clorazepate dipotassium"/><entity id="DrugDDI.d322.s1.e1" origId="s1.p21" charOffset="90-102" type="drug" text="hexobarbital"/><entity id="DrugDDI.d322.s1.e2" origId="s1.p23" charOffset="112-126" type="drug" text="ethyl alcohol"/><entity id="DrugDDI.d322.s1.e3" origId="s1.p26" charOffset="163-177" type="drug" text="chlorpromazine"/><entity id="DrugDDI.d322.s1.e4" origId="s1.p31" charOffset="200-217" type="drug" text="monoamine oxidase"/><pair id="DrugDDI.d322.s1.p0" e1="DrugDDI.d322.s1.e0" e2="DrugDDI.d322.s1.e1" interaction="true"/><pair id="DrugDDI.d322.s1.p1" e1="DrugDDI.d322.s1.e0" e2="DrugDDI.d322.s1.e2" interaction="true"/><pair id="DrugDDI.d322.s1.p2" e1="DrugDDI.d322.s1.e0" e2="DrugDDI.d322.s1.e3" interaction="false"/><pair id="DrugDDI.d322.s1.p3" e1="DrugDDI.d322.s1.e0" e2="DrugDDI.d322.s1.e4" interaction="false"/><pair id="DrugDDI.d322.s1.p4" e1="DrugDDI.d322.s1.e1" e2="DrugDDI.d322.s1.e2" interaction="false"/><pair id="DrugDDI.d322.s1.p5" e1="DrugDDI.d322.s1.e1" e2="DrugDDI.d322.s1.e3" interaction="false"/><pair id="DrugDDI.d322.s1.p6" e1="DrugDDI.d322.s1.e1" e2="DrugDDI.d322.s1.e4" interaction="false"/><pair id="DrugDDI.d322.s1.p7" e1="DrugDDI.d322.s1.e2" e2="DrugDDI.d322.s1.e3" interaction="false"/><pair id="DrugDDI.d322.s1.p8" e1="DrugDDI.d322.s1.e2" e2="DrugDDI.d322.s1.e4" interaction="false"/><pair id="DrugDDI.d322.s1.p9" e1="DrugDDI.d322.s1.e3" e2="DrugDDI.d322.s1.e4" interaction="false"/></sentence><sentence id="DrugDDI.d322.s2" origId="s2" text="Clinical studies have shown increased sedation with concurrent hypnotic medications."><entity id="DrugDDI.d322.s2.e0" origId="s2.p37" charOffset="63-71" type="drug" text="hypnotic"/></sentence><sentence id="DrugDDI.d322.s3" origId="s3" text="The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants."><entity id="DrugDDI.d322.s3.e0" origId="s3.p39" charOffset="19-34" type="drug" text="benzodiazepines"/><entity id="DrugDDI.d322.s3.e1" origId="s3.p43" charOffset="57-69" type="drug" text="barbiturates"/><entity id="DrugDDI.d322.s3.e2" origId="s3.p44" charOffset="71-80" type="drug" text="narcotics"/><entity id="DrugDDI.d322.s3.e3" origId="s3.p45" charOffset="82-96" type="drug" text="phenothiazines"/><entity id="DrugDDI.d322.s3.e4" origId="s3.p46" charOffset="98-126" type="drug" text="monoamine oxidase inhibitors"/><entity id="DrugDDI.d322.s3.e5" origId="s3.p48" charOffset="136-151" type="drug" text="antidepressants"/><pair id="DrugDDI.d322.s3.p0" e1="DrugDDI.d322.s3.e0" e2="DrugDDI.d322.s3.e1" interaction="true"/><pair id="DrugDDI.d322.s3.p1" e1="DrugDDI.d322.s3.e0" e2="DrugDDI.d322.s3.e2" interaction="true"/><pair id="DrugDDI.d322.s3.p2" e1="DrugDDI.d322.s3.e0" e2="DrugDDI.d322.s3.e3" interaction="true"/><pair id="DrugDDI.d322.s3.p3" e1="DrugDDI.d322.s3.e0" e2="DrugDDI.d322.s3.e4" interaction="true"/><pair id="DrugDDI.d322.s3.p4" e1="DrugDDI.d322.s3.e0" e2="DrugDDI.d322.s3.e5" interaction="true"/><pair id="DrugDDI.d322.s3.p5" e1="DrugDDI.d322.s3.e1" e2="DrugDDI.d322.s3.e2" interaction="false"/><pair id="DrugDDI.d322.s3.p6" e1="DrugDDI.d322.s3.e1" e2="DrugDDI.d322.s3.e3" interaction="false"/><pair id="DrugDDI.d322.s3.p7" e1="DrugDDI.d322.s3.e1" e2="DrugDDI.d322.s3.e4" interaction="false"/><pair id="DrugDDI.d322.s3.p8" e1="DrugDDI.d322.s3.e1" e2="DrugDDI.d322.s3.e5" interaction="false"/><pair id="DrugDDI.d322.s3.p9" e1="DrugDDI.d322.s3.e2" e2="DrugDDI.d322.s3.e3" interaction="false"/><pair id="DrugDDI.d322.s3.p10" e1="DrugDDI.d322.s3.e2" e2="DrugDDI.d322.s3.e4" interaction="false"/><pair id="DrugDDI.d322.s3.p11" e1="DrugDDI.d322.s3.e2" e2="DrugDDI.d322.s3.e5" interaction="false"/><pair id="DrugDDI.d322.s3.p12" e1="DrugDDI.d322.s3.e3" e2="DrugDDI.d322.s3.e4" interaction="false"/><pair id="DrugDDI.d322.s3.p13" e1="DrugDDI.d322.s3.e3" e2="DrugDDI.d322.s3.e5" interaction="false"/><pair id="DrugDDI.d322.s3.p14" e1="DrugDDI.d322.s3.e4" e2="DrugDDI.d322.s3.e5" interaction="false"/></sentence><sentence id="DrugDDI.d322.s4" origId="s4" text="If TRANXENE tablets are used to treat anxiety associated with somatic disease states, careful attention must be paid to possible drug interaction with concomitant medication."><entity id="DrugDDI.d322.s4.e0" origId="s4.p49" charOffset="3-11" type="drug" text="TRANXENE"/><entity id="DrugDDI.d322.s4.e1" origId="s4.p62" charOffset="163-174" type="drug" text="medication"/><pair id="DrugDDI.d322.s4.p0" e1="DrugDDI.d322.s4.e0" e2="DrugDDI.d322.s4.e1" interaction="false"/></sentence><sentence id="DrugDDI.d322.s5" origId="s5" text="In bioavailability studies with normal subjects, the concurrent administration of antacids at therapeutic levels did not significantly influence the bioavailability of TRANXENE tablets."><entity id="DrugDDI.d322.s5.e0" origId="s5.p67" charOffset="82-90" type="drug" text="antacids"/><entity id="DrugDDI.d322.s5.e1" origId="s5.p73" charOffset="168-176" type="drug" text="TRANXENE"/><pair id="DrugDDI.d322.s5.p0" e1="DrugDDI.d322.s5.e0" e2="DrugDDI.d322.s5.e1" interaction="false"/></sentence></document>